Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

FFR-guided PCI earns high marks as a treatment option for patients with stable angina pectoris

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

Thumbnail

DAEDALUS study results: How stent type may affect coronary in-stent restenosis treatment

When patients with coronary in-stent restenosis (ISR) require reintervention, should specialists turn to drug-coated balloon (DCB) angioplasty or a drug-eluting stent (DES)?

Thumbnail

Cath labs join forces, reduce radiation dose across the board

Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.

Thumbnail

What we know—and don’t know—about assessing nonculprit lesions after STEMI

How should nonculprit lesions be evaluated? And when is the ideal time for complete revascularization?

Thumbnail

How to make a difference: A helpful guide for hospitals looking to improve their PCI program

What is the best way to determine—and improve—the quality of a PCI program?

Thumbnail

Another way work-related stress can impact your cardiovascular health

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

PCI for small-vessel coronary disease: How should cardiologists proceed?

Newer-generation drug-eluting stents (n-DES) are a more effective option for the percutaneous treatment of small-vessel coronary disease (SVCD) than drug-coated balloons (DCBs), according to new findings published in JACC: Cardiovascular Interventions.

Thumbnail

Women at greater risk of adverse outcomes following PCI

Women are at an increased risk of adverse events following percutaneous coronary intervention (PCI), according to new findings published in the Journal of the American College of Cardiology.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.